
Read More
Biocon Gains 2% After Securing 10-Year Pertuzumab Supply Contract in Brazil...
The partnership with Bahiafarma and Bionovis gives Biocon 100% allocation under Brazil's 10-year Pro...

The partnership with Bahiafarma and Bionovis gives Biocon 100% allocation under Brazil's 10-year Pro...

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to stren...